Clinical Trial Details

EORTC-1726-QLG

Back to Clinical Trials Database

Evaluating the use of the E-PRO measures for improving inter-rater reliability of CTCAE ratings

Study documentation

Trial Status Recruiting
Data management at EORTC None
Design QoL Non Mod Dev.
Not randomized / N.A.
Treatment None
Study Staff Bernhard Holzner (Study Coordinator) , A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Lisa Wintner (Study Co-Coordinator) , A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck
Type of cancer Acute Myelogenous Leukemia
Anal
Biliary Tract
Bladder
Brain
Breast
Cervical
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Colon
Colorectal
Endometrium
Esophageal
Fallopian Tube
Gastric
Head and Neck
Hodgkins Disease
Kidney
Liver
Lung
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndroms
Neuroendocrine
Non Hodgkins Lymphoma
Osteosarcoma
Ovarian
Pancreatic
Penile
Primary Cutaneous Lymphomas
Prostate
Rectal
Refractory Lymphoid Neoplasms
Soft Tissue and Bone Sarcoma
Solid Tumors, Unspecified
Testicular
Thymoma
Thyroid
Uterine
Uveal Melanoma
Vaginal
Vulvar
Participating groups EORTC Quality of Life Group
Protocol summary http://clinicaltrials.gov/study/
NCT number
Financial Support EORTC Group